Exploiting Iron Metabolism as a Therapeutic Vulnerability in Glioblastoma

被引：3
|
作者：
Nabavizadeh, Ali [1 ,3 ]
Bagley, Stephen J. [2 ]
机构：
[1] Univ Penn, Hosp Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA USA
[2] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA
[3] Hosp Univ Penn, Dept Radiol, Silverstein Bldg 3400 Spruce St, Philadelphia, PA 19104 USA
来源：
CLINICAL CANCER RESEARCH | 2024年 / 30卷 / 02期
关键词：
D O I：
10.1158/1078-0432.CCR-23-3027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this CCR Translations, we discuss pharmacologic ascorbate as a novel therapeutic for glioblastoma (GBM). Aberrant iron metabolism in GBM can be assessed noninvasively by MRI and exploited to potentially improve the efficacy of chemoradiotherapy. We contextualize the study's results and discuss the next steps to further develop this paradigm.
引用
收藏
页码：255 / 256
页数：2
相关论文
共 50 条
  • [21] Pharmacological targeting of one‑carbon metabolism as a novel therapeutic strategy for glioblastoma
    Yanfei Sun
    Guangjing Mu
    Zhiwei Xue
    Xingang Li
    Xiaoying Lin
    Mingzhi Han
    Journal of Translational Medicine, 21
  • [22] LIPID METABOLISM AS A THERAPEUTIC VULNERABILITY IN BET INHIBITOR-RESISTANT MEDULLOBLASTOMA
    Lupien, Leslie
    Boynton, Adam
    Kumbhani, Rushil
    Gionet, Gabrielle
    Goodale, Amy
    Root, David
    Bandopadhayay, Pratiti
    NEURO-ONCOLOGY, 2021, 23 : 214 - 214
  • [23] LIPID METABOLISM AS A THERAPEUTIC VULNERABILITY IN BET INHIBITOR-RESISTANT MEDULLOBLASTOMA
    Lupien, Leslie
    Boynton, Adam
    Chacon, Madison
    Kumbhani, Rushil
    Gionet, Gabrielle
    Goodale, Amy
    Root, David
    Keshishian, Hasmik
    Robinson, Margaret
    Carr, Steven
    Bandopadhayay, Pratiti
    NEURO-ONCOLOGY, 2022, 24 : 123 - 123
  • [24] Iron metabolism: a double-edged sword in the resistance of glioblastoma to therapies
    Legendre, Claire
    Garcion, Emmanuel
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2015, 26 (06): : 322 - 331
  • [25] Iron metabolism and arthritis: Exploring connections and therapeutic avenues
    Zhuo, Dachun
    Xiao, Wenze
    Tang, Yulong
    Jiang, Shuai
    Geng, Chengchun
    Xie, Jiangnan
    Ma, Xiaobei
    Zhang, Qing
    Tang, Kunhai
    Yu, Yuexin
    Bai, Lu
    Zou, Hejian
    Liu, Jing
    Wang, Jiucun
    CHINESE MEDICAL JOURNAL, 2024, 137 (14) : 1651 - 1662
  • [26] Iron Metabolism: An Emerging Therapeutic Target in Critical Illness
    Edward Litton
    Jolene Lim
    Critical Care, 23
  • [27] Iron metabolism and arthritis: Exploring connections and therapeutic avenues
    Zhuo Dachun
    Xiao Wenze
    Tang Yulong
    Jiang Shuai
    Geng Chengchun
    Xie Jiangnan
    Ma Xiaobei
    Zhang Qing
    Tang Kunhai
    Yu Yuexin
    Bai Lu
    Zou Hejian
    Liu Jing
    Wang Jiucun
    中华医学杂志英文版, 2024, 137 (14)
  • [28] Current status of iron metabolism: Clinical and therapeutic implications
    Conde Diez, Susana
    de las Cuevas Allende, Ricardo
    Conde Garcia, Eulogio
    MEDICINA CLINICA, 2017, 148 (05): : 218 - 224
  • [29] Therapeutic potential of hepcidin - the master regulator of iron metabolism
    Vyoral, Daniel
    Petrak, Jiri
    PHARMACOLOGICAL RESEARCH, 2017, 115 : 242 - 254
  • [30] Iron Metabolism: An Emerging Therapeutic Target in Critical Illness
    Litton, Edward
    Lim, Jolene
    CRITICAL CARE, 2019, 23 (1)
12345